Nanotechnology reinforced neutrophil-based therapeutic strategies for inflammatory diseases therapy

J Wu, T Ma, M Zhu, T Huang, B Zhang, J Gao, N Lin - Nano Today, 2022 - Elsevier
Misguided attack of immune systems on self-tissue or multifactorial uncontrolled
inflammation is capable of causing inflammatory diseases. Neutrophils play a critical role in …

Strategies targeting tumor immune and stromal microenvironment and their clinical relevance

M Hu, L Huang - Advanced Drug Delivery Reviews, 2022 - Elsevier
The critical role of tumor microenvironment (TME) in tumor initiation and development has
been well-recognized after more than a century of studies. Numerous therapeutic …

d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma

S Han, X Bao, Y Zou, L Wang, Y Li, L Yang, A Liao… - Science …, 2023 - science.org
The polarization of tumor-associated macrophages (TAMs) from M2 to M1 phenotype
demonstrates great potential for remodeling the immunosuppressive tumor …

Amplification of activated near-infrared afterglow luminescence by introducing twisted molecular geometry for understanding neutrophil-involved diseases

C Chen, H Gao, H Ou, RTK Kwok, Y Tang… - Journal of the …, 2022 - ACS Publications
Understanding the mechanism and progression of neutrophil-involved diseases (eg, acute
inflammation) is of great importance. However, current available analytical methods neither …

Macrophage‐hitchhiked orally administered β‐glucans‐functionalized nanoparticles as “precision‐guided stealth missiles” for targeted pancreatic cancer therapy

KH Chen, N Nguyen, TY Huang, YJ Lin… - Advanced …, 2023 - Wiley Online Library
The prognosis in cases of pancreatic ductal adenocarcinoma (PDAC) with current treatment
modalities is poor owing to the highly desmoplastic tumor microenvironment (TME). Herein …

[HTML][HTML] Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma

X Liu, J Zhou, H Wu, S Chen, L Zhang, W Tang… - Molecular Therapy, 2023 - cell.com
The local microenvironment where tumors develop can shape cancer progression and
therapeutic outcome. Emerging evidence demonstrate that the efficacy of immune …

Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy

L Wang, S Bi, Z Li, A Liao, Y Li, L Yang, X Zhou, Y Gao… - Biomaterials, 2025 - Elsevier
The immune resistance of tumor microenvironment (TME) causes immune checkpoint
blockade therapy inefficient to hepatocellular carcinoma (HCC). Emerging strategies of …

[HTML][HTML] Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here?

AR Yoon, JW Hong, BK Jung, HM Ahn, S Zhang… - Cancer Letters, 2023 - Elsevier
Pancreatic cancer remains one of the deadliest cancers with extremely high mortality rate,
and the number of cases is expected to steadily increase with time. Pancreatic cancer is …

Recent advances in drug delivery and targeting for the treatment of pancreatic cancer

N Pramanik, A Gupta, Y Ghanwatkar… - Journal of Controlled …, 2024 - Elsevier
Despite significant treatment efforts, pancreatic ductal adenocarcinoma (PDAC), the
deadliest solid tumor, is still incurable in the preclinical stages due to multifacet stroma …

Immune cell modulation of the extracellular matrix contributes to the pathogenesis of pancreatic cancer

RS Ahmad, TD Eubank, S Lukomski, BA Boone - Biomolecules, 2021 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with a five-year
survival rate of only 9%. PDAC is characterized by a dense, fibrotic stroma composed of …